speb/financial-data huggingface dataset:
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 11259000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 28777000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1486000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 50845000.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 6817000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 52119000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 50336000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 264731000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 25091525.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.18
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 249960000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 8380000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 8380000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 249960000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1102584000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 15001000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 35696000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 991317000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 234021000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 234021000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 310010000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 5968000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 1487000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 1487000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 25091525.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.18
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 29608000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — EBIT: 34945000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — EBITDA: 36432000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 180490000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 16423000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 3767000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 3767000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 398877000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1411427000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 68000000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 74822000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 74822000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 88267000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 300463000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Net Income: 29608000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 29608000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 29608000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Net Income Extraordinary: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 29608000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 29608000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 29608000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -3767000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -3767000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 180490000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1102584000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 208000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 6924000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 36432000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 29608000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Operating Income: 9606000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 52119000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 24996000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 319329000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 19685000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 852624000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 45477000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 8207000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 25339000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 2316000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 165489000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Payables: 50336000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 31178000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 35696000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1487000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 24996000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1102584000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1102584000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 1570000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.05
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 1590814000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1177406000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 308843000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1190851000.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 42513000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 399963000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 599497000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 89953000.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 681307000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 11225000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 66898000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 24945000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.80
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 32775000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1487000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 1487000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 24945000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.80
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 44901000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — EBIT: 54623000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — EBITDA: 56110000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 34123000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 3362000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3362000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Net Income: 44901000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 44901000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 44901000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 44901000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 44901000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 44901000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -3362000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3362000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 56110000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 44901000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Operating Income: 22898000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 66898000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 31725000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 6314000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 51261000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 32775000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1487000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 6359000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.12
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 44000000.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
ASHOKAMET.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — +Operating Expense: 60170000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 20061000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — +Total Revenue: 277025000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 103469000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 68106000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 68106000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 276354000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 276354000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 24996000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 2.62
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 7991000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -44498000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 249960000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 249960000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 17876000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 17876000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 17876000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 17876000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -110952000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -161754000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 38058000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Change In Payable: 17770000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -15049000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -206917000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 9884000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Common Stock: 249960000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 249960000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 1219712000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1219712000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 57301000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 57301000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 160506000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 63258000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Current Assets: 1284501000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 1284501000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Current Debt: 147885000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 147885000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 147885000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 147885000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 303874000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 303874000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 32730000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 32730000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Depreciation: 6219000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 6219000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 8422000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 3963000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 8422000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 3963000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 24996000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.62
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 107998000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 22229000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — EBIT: 152546000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — EBIT: 47867000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — EBITDA: 160968000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — EBITDA: 51830000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — End Cash Position: 17876000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 167074000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -216346000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -8107000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Goodwill: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 0.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 0.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 218912000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 218912000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Gross Profit: 116519000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 40211000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Interest Expense: 14163000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 3182000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 14163000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3182000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -14163000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Inventory: 509829000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 509829000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 1796996000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1796996000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 14658000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 103456000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 103456000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 429399000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 429399000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 429399000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 429399000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 117919000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 117919000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Minority Interests: 0.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 0.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Net Debt: 559408000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 559408000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Net Income: 107998000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Net Income: 22229000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 107998000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 22229000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 107998000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 22229000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Net Income Discontinuous Operations: 0.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 0.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 107998000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 22229000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 107998000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 22229000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 138383000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 107998000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 22229000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Net Interest Income: -14163000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -3182000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 51049000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 98821000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 98821000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -14163000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3182000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: 82416000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 8107000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Net PPE: 218912000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 218912000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -44498000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 1219712000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1219712000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 271000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 271000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 4702000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 4702000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 160968000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 51830000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Normalized Income: 107998000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 22229000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -171848000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Operating Income: 56349000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Operating Income: 20150000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Operating Revenue: 277025000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 103469000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 24996000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 24996000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 480442000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 480442000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 55153000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 55153000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 969752000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 969752000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -70958000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 44472000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 44472000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 8208000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 8208000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 96196000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 27716000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 39259000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 12930000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Other Properties: 161611000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 161611000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Payables: 68106000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Payables: 68106000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Pretax Income: 138383000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 44685000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -58107000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -44498000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 160506000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 63258000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 6219000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3963000.00
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 109156000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Share Issued: 24996000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 24996000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 1219712000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1219712000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 1219712000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1219712000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Tax Provision: 30385000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 22456000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.22
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
ASHOKAMET.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -32670000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Total Assets: 2083814000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 2083814000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 1649111000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1649111000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Total Debt: 577284000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 577284000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 1337631000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1337631000.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Total Expenses: 220676000.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 83319000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 746183000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 746183000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 799312000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 799312000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 442309000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 442309000.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
ASHOKAMET.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ASHOKAMET.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ASHOKAMET.NS balance_sheet (annual, 2026-03-31) — Working Capital: 980627000.00
ASHOKAMET.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 980627000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -37321400000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 20168500000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -1403600000.00
ASHOKLEY.NS income_statement (annual, 2022-03-31) — Amortization: 1946700000.00
ASHOKLEY.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 1946700000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 20265300000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 5213700000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 15095900000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 1238200000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 50500000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 105100000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Financial Assets: 266900000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 6416500000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 6850900000.00
ASHOKLEY.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: 30200000.00
ASHOKLEY.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 6510900000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 34044500000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 193200000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Held To Maturity Securities: 377900000.00
ASHOKLEY.NS income_statement (annual, 2022-03-31) — Interest Income: 277300000.00
ASHOKLEY.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 277300000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 428400000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 37600000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 10958500000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Liabilities Heldfor Sale Non Current: 117800000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 63462300000.00
ASHOKLEY.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -5059000000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 6765400000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Other Payable: 3749200000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2355300000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 13116300000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 15461600000.00
ASHOKLEY.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 152700000.00
ASHOKLEY.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 152700000.00
ASHOKLEY.NS income_statement (annual, 2022-03-31) — Research And Development: 1298300000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 527100000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 30369500000.00
ASHOKLEY.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 6052400000.00
ASHOKLEY.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 6510900000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 37100000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Trading Securities: 2218700000.00
ASHOKLEY.NS balance_sheet (annual, 2022-03-31) — Work In Process: 3093000000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — +Operating Expense: 77132900000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — +Total Revenue: 414883000000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 75818700000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 41873600000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -43123000000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 25476900000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -1464100000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Amortization: 2269000000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 2269000000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 719200000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 3413600000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 5871633182.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Basic EPS: 2.11
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 20309600000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 21556900000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -9291000000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 2404900000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 2936100000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 19085800000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 61469300000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -2935500000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 577600000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 18508200000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -8998800000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -68431100000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 6648200000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Change In Payable: 3200200000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Change In Prepaid Assets: 11900000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -9093000000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -72612300000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -1536300000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Common Stock: 2936100000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 85517600000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 50500000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 1391500000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 289355500000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Current Assets: 242434400000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 515200000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Current Debt: 114175800000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 114691000000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 1283000000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 224549500000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 5865200000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Deferred Tax: 9069300000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Depreciation: 6733200000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 9002200000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 9002200000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 6733200000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 0.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 5877951884.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Diluted EPS: 2.11
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 12387100000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Dividend Paid Cfo: 0.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 103000000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — EBIT: 43584300000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — EBITDA: 52586500000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 27800000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — End Cash Position: 19085800000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Financial Assets: 431400000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 9359900000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 72805900000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 12467900000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -54283600000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -1091800000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: 0.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -98800000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 6843300000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Goodwill: 11925900000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 25123300000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 43337700000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 102144000000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Gross Profit: 125527500000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 557900000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Held To Maturity Securities: 574000000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 0.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Interest Expense: 20935000000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 20935000000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Interest Income: 310300000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 310300000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -3299500000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 352600000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Inventory: 34404300000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 394722000000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -29349600000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 12773500000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 50500000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 205714000000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 10428700000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Liabilities Heldfor Sale Non Current: 108700000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 1889700000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 195028600000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 196918300000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 151401300000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -88323600000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 636600000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 6332800000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 68696900000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 22440500000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Minority Interests: -1201100000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -2184400000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 50500000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Net Debt: 290118600000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 371800000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Net Income: 12387100000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 12387100000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 13588200000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 12387100000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 12387100000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 13588200000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 13588200000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Net Interest Income: -20624700000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -19510600000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 69129800000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 63077700000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -20624700000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 10530300000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -9291000000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Net PPE: 59021000000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -8537200000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 6052100000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 60394300000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 2500400000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 490800000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 7424100000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 7921600000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 58122800000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Normalized Income: 16238880000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -44992600000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Operating Income: 48394600000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Operating Revenue: 414883000000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 5872254552.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 284700000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 65900000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 5916400000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 425400000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 13197400000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Other Investments: 83900000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 3308800000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 3305200000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 136800000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 294300000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 30649200000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Other Payable: 3828900000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Other Properties: 70000000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 89086200000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 42383500000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Other Special Charges: -563800000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Payables: 79750600000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 4710100000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 13767700000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Pretax Income: 22649300000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 0.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -2184400000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -46187000000.00
ASHOKLEY.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -9291000000.00
ASHOKLEY.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 18606600000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 289355500000.00
ASHOKLEY.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 9002200000.00